Encontrados 3 documentos, a visualizar página 1 de 1

Ordenado por Data

Estudo comparativo, aleatorizado, em dupla ocultação, de orlistat versus placeb...

Castro, JJ; Dias, T; Chambel, P; Carvalheiro, M; Correia, LG; Guerreiro, L; Marques, O; Medina, JL; Nobre, E; Nunes, JS; Pereira, MC; Polónia, J

INTRODUCTION: Obesity is a chronic disease and a serious health problem that leads to increased prevalence of diabetes, hypertension, dyslipidemia and gallbladder disease. OBJECTIVE: To evaluate the efficacy of orlistat for weight loss and improved lipid profile compared to placebo in obese patients with hypercholesterolemia, treated over a period of 6 months. METHODOLOGY: In a 6-month, multicenter (10 center...


Estudo Comparativo, Aleatorizado, em Dupla Ocultação, de Orlistat Versus Placeb...

Castro, JJ; Dias, T; Chambel, P; Carvalheiro, M; Correia, LG; Guerreiro, L; Marques, O; Medina, JL; Nobre, E; Silva Nunes, J; Pereira, MC; Polónia, J

INTRODUCTION: Obesity is a chronic disease and a serious health problem that leads to increased prevalence of diabetes, hypertension, dyslipidemia and gallbladder disease. OBJECTIVE: To evaluate the efficacy of orlistat for weight loss and improved lipid profile compared to placebo in obese patients with hypercholesterolemia, treated over a period of 6 months. METHODOLOGY: In a 6-month, multicenter (10 center...


Obesity and quality of life.

Da Silva, M Paes; Jorge, Z; Domingues, A; Nobre, E Lacerda; Chambel, P; De Castro, J Jácome

Obesity is considered one of the most relevant health problems of modern societies, as it constitutes a predominant risk factor in the development of various other diseases. The negative impact of obesity on the quality of life of individuals has been the subject of diverse research. The results of a test carried out at Gothenburg University in Sweden suggest that severe obesity is a debilitating factor both fo...

Data: 2006   |   Origem: Acta Médica Portuguesa

3 Resultados

Texto Pesquisado

Refinar resultados

Autor











Data



Tipo de Documento


Recurso




Assunto















    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia